Employee Management
RSSArticles
-
Kaizen Method Can Improve Case Management
Efficiency and cost savings are worthy goals. Satisfaction also is relevant, whether applied to patients, frontline staff, managers, or chief executive officers. If your hospital workday is inefficient, satisfaction suffers at all levels. That is where the Kaizen method can help.
-
Medical Records in the COVID-19 Era: Renewing the Case for Interoperability
The problems of electronic medical records (EMRs) have been all too real during this pandemic. Patients with life-threatening COVID-19 symptoms have gone to hospitals without family or friends. They may not recall critical details of their medical history, including medications. At the crux of this crisis is the patient’s EMR, which holds important details that help providers make treatment decisions. Too often in hospitals, healthcare providers cannot access all these records, which is frustrating for everyone.
-
Look for Undocumented Social Determinants of Health in Patient Charts
One conundrum for hospital case managers involves identifying patients’ social determinants of health needs when the hospital record does not list all these data. The visible data could be missing critical factors related to why patients are returning to emergency departments or are not taking their medications.
-
COVID-19 Can Cause Neurological Symptoms and Strokes in Patients
One major health problem related to COVID-19 involves neurological symptoms and signs of brain injury. Patients with COVID-19 can experience acute periods of confusion, post-traumatic amnesia, and delirium. Physicians and researchers do not know what will happen to patients with COVID-19 over the long term and whether they will fully regain their prior cognitive status.
-
Case Managers Can Guide Patients with COVID-19 to Rehab Services
After days, weeks, or even months of hospitalization with COVID-19, patients often need considerable help with their post-discharge recovery. This is especially true for people who need pulmonary, brain injury, or cardiac rehabilitation. Hospital case managers can help patients recover by educating them about various rehabilitation services.
-
Lessons Learned — or Not — from Hydroxychloroquine Mishap
The research community’s decades of work to build public trust in IRB oversight and the clinical trial process has reached one of its greatest challenges during the COVID-19 pandemic. Misinformation spread through social media and some media outlets, as well as contradictory instructions and information from political and public health officials, have helped create distrust. Through the spring of 2020, misinformation about hydroxychloroquine as a COVID-19 therapeutic proliferated after President Trump spoke about it as a cure.
-
Minority Recruitment for COVID-19 Trials Is Low While Disease Burden Is High
More than 350,000 people said they were interested in volunteering for a COVID-19 vaccine trial in the United States, and only 10% of those who signed up are Black and Hispanic. Actual trial enrollment among two companies with large COVID-19 vaccine trials in the U.S. includes only one in five volunteers who are Black and Hispanic.
-
COVID-19 Misinformation Affects Everyone in Research Community
Clinical trial recruitment for COVID-19 studies faces a new challenge: Rampant misinformation. Since COVID-19 was declared a national emergency and pandemic, fake news, false cures, ill-informed posts, and conspiracy theories have dominated the social media space. One of the challenges from an IRB perspective involves informed consent and public trust in the shadows of the misinformation world.
-
Vaccine Trials Should Follow the Four Ethical Principles
All human research, including COVID-19 vaccine trials, should be guided by the four ethical principles of autonomy, beneficence, nonmaleficence, and justice. When researchers, data safety monitoring boards, or the Food and Drug Administration decide to stop a clinical trial or expedite approval or use of an investigational product, these principles still apply.
-
A COVID-19 Vaccine at ‘Warp Speed’ Raises Myriad Ethical Questions
The United States is at a challenging and possibly dangerous crossroad as the desire for speedy development of a COVID-19 vaccine might be pushing political concerns ahead of safety, efficacy, and the regulatory process, bioethicists and researchers say.